Literature DB >> 2929849

In vitro activity of antimalarial compounds on the exoerythrocytic stages of Plasmodium cynomolgi and P. knowlesi.

T L Fisk1, P Millet, W E Collins, P Nguyen-Dinh.   

Abstract

Primary cultures of Macaca mulatta hepatocytes infected with sporozoites of Plasmodium knowlesi, P. cynomolgi (Cambodian strain), and P. cynomolgi bastianellii were exposed in vitro to 7 antimalarial compounds. The number of exoerythrocytic schizonts present after 4-7 days of culture was used to assess the activity. With pyrimethamine, proguanil, cycloguanil, primaquine, and 2 of its analogues (WR242511 and WR238605), marked inhibition of schizont formation could be achieved at concentrations below those causing a cytotoxic effect on the host hepatocytes. Chloroquine had only minimal schizonticidal activity at a concentration that produced severe hepatocyte toxicity. This simian in vitro system provides a reliable model for screening antimalarial compounds and for investigating their effects on the hepatic stage of malaria parasites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2929849     DOI: 10.4269/ajtmh.1989.40.235

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

2.  In vitro activity of cycloguanil against African isolates of Plasmodium falciparum.

Authors:  L K Basco; O Ramiliarisoa; P Ringwald; J C Doury; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  Effects of Plasmodium falciparum parasite population size and patient age on early and late parasitological outcomes of antimalarial treatment in children.

Authors:  Steffen Borrmann; Pierre-Blaise Matsiegui; Michel Anoumou Missinou; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

4.  Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery.

Authors:  Laurent Dembele; Audrey Gego; Anne-Marie Zeeman; Jean-François Franetich; Olivier Silvie; Armelle Rametti; Roger Le Grand; Nathalie Dereuddre-Bosquet; Robert Sauerwein; Geert-Jan van Gemert; Jean-Christophe Vaillant; Alan W Thomas; Georges Snounou; Clemens H M Kocken; Dominique Mazier
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

5.  Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.

Authors:  Rana Chattopadhyay; Soundarapandian Velmurugan; Chinnamma Chakiath; Lucy Andrews Donkor; Wilbur Milhous; John W Barnwell; William E Collins; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

6.  HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.

Authors:  Charlotte V Hobbs; Jillian Neal; Solomon Conteh; Liam Donnelly; Jingyang Chen; Kennan Marsh; Lynn Lambert; Sachy Orr-Gonzalez; Jessica Hinderer; Sara Healy; William Borkowsky; Scott R Penzak; Sumana Chakravarty; Stephen L Hoffman; Patrick E Duffy
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

7.  Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.

Authors:  Charlotte V Hobbs; Saurabh Dixit; Scott R Penzak; Tejram Sahu; Sachy Orr-Gonzalez; Lynn Lambert; Katie Zeleski; Jingyang Chen; Jillian Neal; William Borkowsky; Yimin Wu; Patrick E Duffy
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

8.  Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.

Authors:  Ivo H J Ploemen; Miguel Prudêncio; Bruno G Douradinha; Jai Ramesar; Jannik Fonager; Geert-Jan van Gemert; Adrian J F Luty; Cornelus C Hermsen; Robert W Sauerwein; Fernanda G Baptista; Maria M Mota; Andrew P Waters; Ivo Que; Clemens W G M Lowik; Shahid M Khan; Chris J Janse; Blandine M D Franke-Fayard
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

9.  Chloroquine neither eliminates liver stage parasites nor delays their development in a murine Chemoprophylaxis Vaccination model.

Authors:  Tejram Sahu; Lynn Lambert; Jessica Herrod; Solomon Conteh; Sachy Orr-Gonzalez; Dariyen Carter; Patrick E Duffy
Journal:  Front Microbiol       Date:  2015-04-09       Impact factor: 5.640

10.  KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.

Authors:  Anne-Marie Zeeman; Sandra M van Amsterdam; Case W McNamara; Annemarie Voorberg-van der Wel; Els J Klooster; Alexander van den Berg; Edmond J Remarque; David M Plouffe; Geert-Jan van Gemert; Adrian Luty; Robert Sauerwein; Kerstin Gagaring; Rachel Borboa; Zhong Chen; Kelli Kuhen; Richard J Glynne; Arnab K Chatterjee; Advait Nagle; Jason Roland; Elizabeth A Winzeler; Didier Leroy; Brice Campo; Thierry T Diagana; Bryan K S Yeung; Alan W Thomas; Clemens H M Kocken
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.